SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 5.30 |
Enterprise Value ($M) | 8.27 |
Book Value ($M) | -1.67 |
Book Value / Share | -0.50 |
Price / Book | -3.18 |
NCAV ($M) | -5.99 |
NCAV / Share | -1.79 |
Price / NCAV | -0.88 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.97 |
Return on Assets (ROA) | -0.47 |
Return on Equity (ROE) | -4.96 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.40 |
Current Ratio | 0.70 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 6.19 |
Assets | 10.52 |
Liabilities | 12.18 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 5.61 |
Operating Income | -7.36 |
Net Income | -6.29 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -6.58 |
Cash from Investing | 3.82 |
Cash from Financing | 3.76 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Armistice Capital, Llc | 9.99 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
150,142 | 716,684 | 20.95 | |
555,935 | 2,047,427 | 27.15 | |
61,301 | 359,197 | 17.07 | |
90,115 | 475,010 | 18.97 | |
193,314 | 563,844 | 34.29 | |
(click for more detail) |
Similar Companies | |
---|---|
APTO – Aptose Biosciences Inc. | APVO – Aptevo Therapeutics Inc. |
ARTL – Artelo Biosciences, Inc. | ASRT – Assertio Holdings, Inc. |
ATNF – 180 Life Sciences Corp. |
Financial data and stock pages provided by
Fintel.io